Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors

NCT05082545 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SHR-2002 and SHR-1316

Sponsor

Atridia Pty Ltd.